Event Start Date:
Wednesday, November 1, 2023 - 8:00am
Event End Date:
Wednesday, November 1, 2023 - 6:15pm
Event Location:
Belfer Research Building
The Cancer Research & Treatment Fund (CR&T) is proud to host the 12th International Patient Symposium for individuals with myeloproliferative neoplasms (MPNs), their family, and friends.
Patients and guests attending this day-long symposium will learn about the latest research developments and treatment practices from distinguished MPN researchers and physicians. This is a unique opportunity to engage with guest speakers from the most prestigious cancer centers in the world.
Speakers/Topics include:
Drivers of Progression of MPNs: Ronald Hoffman, M.D.Managing Essential Thrombocythemia in 2023: Ellen K. Ritchie, M.D.The Microbiomes in the MPNs: Hans Hasselbalch, M.D., Ph.D.Managing Polycythemia Vera in 2023: Richard T. Silver, M.D.Inflammation in MPNs: Angela Fleischman, M.D., Ph.D.Managing Myelofibrosis in 2023: Jerry L. Spivak, M.D.Promising new drugs for MPN therapy: Naveen Pemmaraju, M.D.Demystifying bone marrow transplant for MPNs: Roni Tamari, M.D.Moderated Q&A: Ghaith Abu-Zeinah, M.D. - Moderator, and Entire Panel Disease-Specific Q&A Groups (moderated by Symposium presenters): Polycythemia Vera - Drs. Abu-Zeinah, Hasselbach, Hoffman, and SilverEssential Thrombocythemia - Drs. Fleischman, Ritchie, and SchaferMyelofibrosis - Drs. Pemmaraju, Spivak, and TamariRegistration Includes:
Continental BreakfastConference program and materials Access to all sessionsMorning and afternoon coffee/snack breaksAccess to sponsor tablesBox LunchAdmission to the evening wine/cheese receptionDiscount code to MPN CongressScholarships available. Please contact Chad Feay at cfeay@crt.org for assistance.
Dress: Business casual